期刊
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 38, 期 4, 页码 345-349出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/S0223-5234(03)00047-3
关键词
phosphopantetheine adenylyltransferase; inhibitors; E coli; co-crystal structure; H-bonding; parallel synthesis
Phosphopantetheine adenylyltransferase (PPAT) is an essential enzyme in Coenzyme A biosynthesis. Because bacterial PPAT and mammalian PPAT are dissimilar, this enzyme is an attractive antibacterial target. Based on the structure of the substrate, 4-phosphopantetheine, a dipeptide library was designed, synthesised and tested against Escherichia coli PPAT. The most potent inhibitor PTX040334 was co-crystallised with E coli PPAT. With this structural information, a rational iterative medicinal chemistry program was initiated, aimed at increasing the number of inhibitor-enzyme interactions. A very potent and specific inhibitor. PTX042695, with an IC50 of 6 nM against E.coli PPAT, but with no activity against porcine PPAT, was obtained. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据